SC
EBS icon

Schubert & Co’s Emergent Biosolutions EBS Stock Holding History

Schubert & Co’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4
Closed -$42 – 479
2023
Q1 		$42 Hold
4
– – ﹤0.01% 1641
2022
Q4 		$47 Hold
4
– – ﹤0.01% 1614
2022
Q3 		$0 Sell
4
-28
-88% -$779 ﹤0.01% 1430
2022
Q2 		$1K Buy
32
+25
+357% +$854 ﹤0.01% 1063
2022
Q1 		$0 Buy
7
+3
+75% +$132 ﹤0.01% 1141
2021
Q4 		$0 Buy
+4
New +$181 ﹤0.01% 1074

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schubert & Co's EBS Position: Q2 2023 in Review

Schubert & Co sold out of Emergent Biosolutions (EBS) in Q2 2023, closing a stake of 4 shares — an estimated $42 sold.

Schubert & Co first reported a position in EBS in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q2 2022. 183 funds tracked by Wall St. Rank hold EBS as of Q2 2023.

  • Schubert & Co reported no remaining Emergent Biosolutions position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 4 Emergent Biosolutions shares in Q2 2023, an estimated $42.
  • Schubert & Co first reported a position in Emergent Biosolutions in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Emergent Biosolutions position peaked at $1K in Q2 2022.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.